Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Ovid Therapeutics Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 69 | 1 | 64 | −4 |
| Shares | 41.0M | 99.0K | 42.3M | +1.44M (+3.5%) |
| Value | $134.5M | $324.6K | $162.6M | +$28.4M (+21.2%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 26,064 | $100.0K | 0.00% |
| Deutsche Bank AG | 24,020 | $92.2K | 0.00% |
| Jump Financial, LLC | 15,811 | $60.7K | 0.00% |
| Allspring Global Investments Holdings, LLC | 6,294 | $24.2K | 0.00% |
| Russell Investments Group, Ltd. | 57 | $219 | 0.00% |
Sold out (9)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tejara Capital Ltd | 112,591 | $369.3K |
| Citadel Advisors LLC | 30,812 | $101.1K |
| Marshall Wace, LLP | 30,017 | $98.5K |
| Occudo Quantitative Strategies LP | 25,590 | $83.9K |
| Raymond James & Associates | 25,000 | $82.0K |
| Susquehanna International Group, LLP | 16,958 | $55.6K |
| Newman Dignan & Sheerar, Inc. | 16,522 | $54.2K |
| State of Wyoming | 403 | $1.32K |
| ICA Group Wealth Management, LLC | 55 | $180 |
Not filed for Q3 2023 yet (1)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EA Series Trust | 98,952 | $324.6K |